Skip to main content

1 Result(s)

within Medicine & Public Health Remove this filter Pathology Remove this filter Hiroaki Sakamoto Remove this filter

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations

Include preview-only content

  1. Article

    Open Access

    Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer

    Afatinib, a second-generation epidermal growth factor receptor (EGFR)—tyrosine kinase inhibitor (TKI) for mutant non-small cell lung cancer (NSCLC), was approved in Japan in 2014. This study evaluated clinical...

    Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka… in Medical Oncology (2019)

    Download PDF (1007 KB) View Article